Literature DB >> 10745073

Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrate-independent manner.

R P Menon1, M Strom, R C Hughes.   

Abstract

We have used the yeast two-hybrid system to search for cytoplasmic proteins that might assist in the intracellular trafficking of the soluble beta-galactoside-binding protein, galectin-3. We utilised as bait murine full-length galectin-3 to screen a murine 3T3 cDNA library. Several interacting clones were found to encode a partial open reading frame and a full-length clone was obtained by rapid amplification of cDNA ends methodology. In various assays in vitro the novel protein was shown to bind galectin-3 in a carbohydrate-independent manner. The novel protein contains an unusually high content of cysteine and histidine residues and shows significant sequence homologies with several metal ion-binding motifs present in known proteins. Confocal immunofluorescence microscopy of permeabilised 3T3 cells shows a prominent perinuclear, as well as cytoplasmic, localisation of the novel protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10745073     DOI: 10.1016/s0014-5793(00)01310-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose.

Authors:  D T Klink; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

2.  Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein.

Authors:  J W Park; P G Voss; S Grabski; J L Wang; R J Patterson
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.

Authors:  Jon B Klein; Michael E Brier; Michael L Merchant; Adam E Gaweda; Andrew J Dailey; Daniel W Wilkey; Xiaolan Zhang; Brad H Rovin
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

4.  Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3.

Authors:  Richard M Gray; Michael J Davis; Katherine M Ruby; Patricia G Voss; Ronald J Patterson; John L Wang
Journal:  Arch Biochem Biophys       Date:  2008-04-18       Impact factor: 4.013

Review 5.  Dynamics of galectin-3 in the nucleus and cytoplasm.

Authors:  Kevin C Haudek; Kimberly J Spronk; Patricia G Voss; Ronald J Patterson; John L Wang; Eric J Arnoys
Journal:  Biochim Biophys Acta       Date:  2009-07-16

Review 6.  Galectin-3: its role in asthma and potential as an anti-inflammatory target.

Authors:  Peng Gao; Jodie L Simpson; Jie Zhang; Peter G Gibson
Journal:  Respir Res       Date:  2013-12-09

7.  Proteomic identification of galectin-11 and 14 ligands from Haemonchus contortus.

Authors:  Dhanasekaran Sakthivel; Jaclyn Swan; Sarah Preston; M D Shakif-Azam; Pierre Faou; Yaqing Jiao; Rachael Downs; Harinda Rajapaksha; Robin Gasser; David Piedrafita; Travis Beddoe
Journal:  PeerJ       Date:  2018-03-19       Impact factor: 2.984

Review 8.  Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target.

Authors:  Milica Velickovic; Aleksandar Arsenijevic; Aleksandar Acovic; Dragana Arsenijevic; Jelena Milovanovic; Jelena Dimitrijevic; Zeljko Todorovic; Marija Milovanovic; Tatjana Kanjevac; Nebojsa Arsenijevic
Journal:  Front Pharmacol       Date:  2021-03-19       Impact factor: 5.810

Review 9.  Galectin-3 in Cardiovascular Diseases.

Authors:  Valeria Blanda; Umberto Marcello Bracale; Maria Donata Di Taranto; Giuliana Fortunato
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

Review 10.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.

Authors:  Salvatore Sciacchitano; Luca Lavra; Alessandra Morgante; Alessandra Ulivieri; Fiorenza Magi; Gian Paolo De Francesco; Carlo Bellotti; Leila B Salehi; Alberto Ricci
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.